loadpatents
Patent applications and USPTO patent grants for Ambrose; Christine.The latest application filed is for "methods of modulating immune responses using bcma polypeptide".
Patent | Date |
---|---|
Methods Of Modulating Immune Responses Using Bcma Polypeptide App 20200095305 - Browning; Jeffrey ;   et al. | 2020-03-26 |
Methods of modulating immune responses using BCMA polypeptide Grant 10,494,416 - Browning , et al. De | 2019-12-03 |
Methods Of Modulating Immune Responses Using Bcma Polypeptide App 20180273605 - Browning; Jeffrey ;   et al. | 2018-09-27 |
Methods of treating autoimmune diseases using a B-cell maturation antigen (BCMA) Grant 9,650,430 - Browning , et al. May 16, 2 | 2017-05-16 |
Taci As An Anti-tumor Agent App 20150218247 - Ambrose; Christine ;   et al. | 2015-08-06 |
Baff Receptor (bcma), An Immunoregulatory Agent App 20150139992 - Browning; Jeffrey ;   et al. | 2015-05-21 |
Methods Of Modulating Immunological Responses By Administering Truncated Baff Receptors App 20150023961 - Ambrose; Christine ;   et al. | 2015-01-22 |
Methods of screening for a compound that inhibits the interaction between BAFF and BCMA Grant 8,828,669 - Browning , et al. September 9, 2 | 2014-09-09 |
Method of treating B cell cancers by administering truncated BAFF receptors Grant 8,821,883 - Ambrose , et al. September 2, 2 | 2014-09-02 |
Method of Treating Immunological Disorders by Administering Truncated BAFF Receptors App 20130177558 - Ambrose; Christine ;   et al. | 2013-07-11 |
Method of treating immunological disorders by administering truncated BAFF receptors Grant 8,303,958 - Ambrose , et al. November 6, 2 | 2012-11-06 |
Taci As An Anti-tumor Agent App 20120189634 - Ambrose; Christine ;   et al. | 2012-07-26 |
Truncated Baff Receptors App 20110311530 - Ambrose; Christine ;   et al. | 2011-12-22 |
Truncated BAFF receptors Grant 8,022,182 - Ambrose , et al. September 20, 2 | 2011-09-20 |
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20100233179 - Browning; Jeffrey ;   et al. | 2010-09-16 |
Truncated BAFF Receptors App 20100184951 - Ambrose; Christine ;   et al. | 2010-07-22 |
Truncated baff receptors Grant 7,700,317 - Ambrose , et al. April 20, 2 | 2010-04-20 |
Methods of treating a tumor that expresses APRIL by administering BCMA Grant 7,276,241 - Schneider , et al. October 2, 2 | 2007-10-02 |
Truncated baff receptors App 20060234917 - Ambrose; Christine ;   et al. | 2006-10-19 |
Methods of treatment by administering an anti-BCMA antibody Grant 7,083,785 - Browning , et al. August 1, 2 | 2006-08-01 |
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20060079457 - Browning; Jeffrey ;   et al. | 2006-04-13 |
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20050169924 - Browning, Jeffrey ;   et al. | 2005-08-04 |
Heterologous polypeptide of the TNF family App 20050124543 - Rennert, Paul ;   et al. | 2005-06-09 |
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20050100548 - Browning, Jeffrey ;   et al. | 2005-05-12 |
Heterologous polypeptide of the TNF family Grant 6,875,846 - Rennert , et al. April 5, 2 | 2005-04-05 |
BAFF, inhibitors thereof and their use in the modulation of B-cell response Grant 6,869,605 - Browning , et al. March 22, 2 | 2005-03-22 |
Taci as an anti-tumor agent App 20040013674 - Ambrose, Christine ;   et al. | 2004-01-22 |
April receptor (BCMA) and uses thereof App 20030082175 - Schneider, Pascal ;   et al. | 2003-05-01 |
Heterologous polypeptide of the TNF family App 20030023038 - Rennert, Paul ;   et al. | 2003-01-30 |
BAFF receptor (BCMA), an immunoregulatory agent App 20020165156 - Browning, Jeffrey ;   et al. | 2002-11-07 |
BAFF, inhibitors thereof and their use in the modulation of B-cell response App 20020037852 - Browning, Jeffrey ;   et al. | 2002-03-28 |
DNA encoding a protein-coupled receptor kinase Grant 5,366,889 - MacDonald , et al. November 22, 1 | 1994-11-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.